Government Relations

Recent Activities

• RSNA Submits Testimony to Senate Appropriators on Radiology’s Critical Role in Patient Care

  Chair of the RSNA Board of Directors, Carolyn Meltzer, MD, submitted written testimony to the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies on May 22. In her testimony, Dr. Meltzer urged members of Congress to provide $51.3 billion in funding for the National Institutes of Health (NIH) in FY27. Read the testimony.

• RSNA Joins Coalition to Reject Proposed Health IT Cuts for FY 2027

  RSNA recently joined a coalition of 13 organizations urging Congress to oppose the Trump Administration’s proposed 30% reduction in funding to the HHS Office of the National Coordinator for Health Information Technology (ONC) in Fiscal Year (FY) 2027. ONC plays a critical role in supporting patient-provider relationships by ensuring that health information can be shared across care settings. Read the letter.

• Advancing Radiology Research: RSNA Joins Friends of NIBIB

  In March, RSNA joined the Friends of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) coalition to support efforts aimed at increasing public awareness and support for NIBIB’s scientific and training programs. NIBIB funds research in biomedical imaging and informatics.

• FY 2027 NIH Funding Recommendation

  RSNA joined over 500 medical research stakeholder organizations in recommending a funding level of at least $51.3 billion for the NIH in FY 2027. Read the recommendation letter.

• RSNA Jointly Urges ASTP to Improve Guidelines for Medical Imaging

  On March 16, RSNA joined ACR, AAPM, ASRT and SNMMI in urging the federal government to treat imaging interoperability as a national priority, comparable to EHR interoperability—while avoiding unfunded mandates or new compliance burdens, particularly for resource-constrained providers. Read the response.

• RSNA Responds to FDA on Premarket Review

  RSNA’s comments stated the Society’s opposition to granting an exemption from premarket review and urged the FDA to instead develop a regulatory framework that modernizes existing systems, protects patient safety, preserves clinical trust, and maintains effective oversight while supporting responsible innovation. Read the response.

• RSNA Responds to HTI-5 Proposed Rule

  RSNA’s comments emphasized the need to fully integrate diagnostic imaging in health data exchange and to promote consistent, clinically meaningful transparency for AI-enabled decision support tools. Read the response.

• RSNA Responds to ASTP regarding AI Adoption in Clinical Care

  On Feb. 23, RSNA responded to the Assistant Secretary for Technology Policy (ASTP) Request for Information on Accelerating the Adoption and Use of AI as Part of Clinical Care. RSNA’s comments highlighted the need for regulatory frameworks to prioritize standards, transparency, explainability, post-deployment monitoring, and lifecycle management to ensure AI tools safely support radiologists’ clinical judgment. Read the response.

• RSNA Joins Coalition Urging Congress to Pass 2026 Funding for NIH

  On Jan. 20, RSNA joined 142 organizations in signing a letter urging congressional leaders to pass the fiscal year (FY) 2026 National Institutes of Health (NIH) spending bill by providing no less than $48.7 billion in funding for the agency. Read the full letter.

• RSNA Responds to Request for Comment from the FDA on Measuring and Evaluating AI Enabled Medical Devices

  In December, RSNA responded to the FDA highlighting the importance of quality datasets, standardized benchmarks and governance principles to ensure transparency, patient safety and interoperability. The comments also addressed monitoring challenges including data drift and automation bias in the deployment of AI-enabled medical devices. Read the full letter.

• White House Office of Science and Technology Policy Inquires about AI Regulation

  In late October, RSNA submitted comments in response to the White House Office of Science and Technology Policy’s Request for Information on the best practices for regulating AI. RSNA’s comments emphasized the need for regulation that is smart, adaptive and grounded in the shared responsibility to protect patients. The comments also highlight how outdated policies, misaligned regulatory frameworks, underused administrative tools, poor cross-agency collaboration and patient trust are all critical factors to consider when attempting to improve the AI regulatory environment. Read the full letter.

• RSNA Urges Congress to Finalize 2026 Funding for NIH

  RSNA joined 454 organizations asking Congress to provide $47.2 billion for the NIH in its FY 2026 appropriations. Read the full letter.

• RSNA Supports New FAIR Model for Essential Research Costs

  RSNA joined in a coalition with 63 other organizations in supporting the FAIR research model. Read the full letter.

• RSNA Congratulates Assistant Secretary Keane on Landmark Appointment

  Radiologist and technology developer Thomas Keane, MD, MBA, was recently appointed the second Assistant Secretary for Technology Policy (ASTP) and ninth National Coordinator for Health Information Technology at the Department Health and Human Services. RSNA congratulated Dr. Keane on his appointment as the first radiologist to hold this position. In our letter, we emphasized RSNA’s leadership in advancing AI and medical imaging and the Society’s commitment to improving interoperability in health care. We look forward to collaborating with Dr. Keane and the ASTP team. Read the full letter.

• NIH Seeks Comments on the Agency’s AI Strategic Plan; RSNA Responds

  RSNA provided comments at the request of the NIH on its development of an AI strategic plan that will be used by the agency to guide AI-related initiatives, policy and funding opportunities. Read the full letter.

• RSNA Jointly Urges Congress to Preserve and Protect NIH Funding in FY 2025 and FY 2026

  This coalition letter to congressional leadership expresses the NIH community’s strong concerns regarding actions being taken by HHS and the Trump Administration to prevent or delay FY 2025 appropriated funds from being disbursed; states opposition to the major structural reorganization in process at NIH that is happening without congressional oversight and urges Congress to take action to protect U.S. leadership in medical research. Read the full letter.

• RSNA Calls on Congress to Safeguard NIH Funding for FY 2026

  This coalition letter to the Congressional Appropriations Committees urges Congress to reject the proposed 38% cut to the NIH included in President Trump’s FY 2026 budget request and to act to protect indirect cost policies for NIH grants. Read the full letter.

• RSNA Joins Coalition to Urge Congress to provide $1.7B ARPA-H Funding for FY 2026

  This coalition letter to the Congressional Appropriations Committees urges Congress to provide at least $1.7 billion in funding for ARPA-H in FY 2026. Read the full letter.

• RSNA Joins Coalition Backing $51.3B NIH Funding for FY 2026

  The coalition letter to the Congressional Appropriations Committees endorses the community’s FY 2026 funding recommendation for the NIH–$51.3 billion. Read the full letter.

Contact Us

For questions or assistance, please contact RSNA Government Relations.

Contact Us